| Name | Title | Contact Details |
|---|
We empower greater health. Today, we have access to highly personalized and useful information in almost every area of our lives; our money, transportation, food, exercise, entertainment, and home security yet we don’t have this same access to the data and insights contained in our personal health records. The current healthcare system is highly complex and constrains the flow of useful information; patient health data and medical records are stored in hundreds of different systems, across thousands of independent organizations in millions of different formats. We simplify this complexity to securely connect healthcare decision-makers to the clinical data and hidden insights contained in patent medical records so that they can deliver greater outcomes at lower costs.
Kaiser Permanente is an American integrated managed care consortium, based in Oakland, California, United States, founded in 1945 by industrialist Henry J.
Eurofins Scientific Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Eurofins Scientific Inc is based in Des Moines, IA. You can find more information on Eurofins Scientific Inc at www.eurofinsus.com
United Health Programs is a Plainview, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.